RANBAXY (MALAYSIA) SDN. BHD

RANBAXY (MALAYSIA) SDN. BHD. Company Introduction:

RANBAXY (MALAYSIA) SDN. BHD. was the Malaysian subsidiary of Ranbaxy Laboratories Limited, a leading global pharmaceutical company originally headquartered in India. The company was actively engaged in the pharmaceutical sector, focusing on the research, development, manufacturing, and marketing of a diverse portfolio of generic and branded prescription drugs, over-the-counter (OTC) medications, and active pharmaceutical ingredients (APIs). It aimed to provide accessible and high-quality healthcare solutions to the Malaysian populace and served as a base for regional distribution. Following the global acquisition of Ranbaxy Laboratories Limited by Sun Pharmaceutical Industries Ltd., the operations and corporate identity of RANBAXY (MALAYSIA) SDN. BHD. were subsequently integrated into Sun Pharma's broader international operations.

Factory or Trader:

RANBAXY (MALAYSIA) SDN. BHD. was primarily a **factory (manufacturer)**, possessing manufacturing facilities in Malaysia, alongside its significant activities in the marketing, sales, and distribution of pharmaceutical products.

RANBAXY (MALAYSIA) SDN. BHD, which is now part of Sun Pharmaceutical Industries Ltd., primarily produced and sold a range of generic pharmaceutical products across various therapeutic areas in Malaysia. These products are designed to treat a wide array of health conditions.

The main product categories and therapeutic areas include:

Cardiovascular Products

Gastrointestinal Products

Anti-infective Products

Central Nervous System Products

Pain Management Products

Respiratory Products

Dermatology Products

Diabetology Products

Oncology Products

Vitamins, Minerals and Nutrients